A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
26 Sep 2026 · 02:40 CST Terminal Access 终端入口 →
688373.SH上海证券交易所 · 科创板 STAR

Micurx 盟科药业

Chemical Pharmaceuticals 化学制药
¥5.86−¥0.16 · −2.66%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥6.01
High 最高
¥6.14
Low 最低
¥5.85
Prev Close 昨收
¥6.02
Volume 成交量
1,845.3万股
Turnover 成交额
¥1.10亿
Mkt Cap 总市值
¥38亿
P/E 市盈率
−27.4×
Recent Activity 近期动态All Filings 全部公告 →

7 significant filings since 29 May 2026: 1 on litigation, 2 on major holder selling and 2 on equity incentive, and 1 other kind. The latest, on 25 Sep 2026: 上海盟科药业股份有限公司关于美国子公司诉讼进展的公告.
自 29 May 2026 起有 7 份重大公告:litigation 1 份、major holder selling 2 份、equity incentive 2 份,另有 1 类。最新一份(25 Sep 2026):上海盟科药业股份有限公司关于美国子公司诉讼进展的公告。

Price History 价格走势

250 trading days 个交易日 · High 最高 ¥9.71 · Low 最低 ¥4.21
5.006.007.008.009.00
Volume 成交量
1.07亿
Sep 25Dec 25Mar 26Jun 26Sep 26

Against Its Own History 与自身历史比较

−27.4×
No history to compare
23.60×
Median 中值 5.37× · Range 区间 3.65× to 23.19× · 16 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥4.53−¥0.22—¥0.2518.24×
31 Mar 2026 一季报¥6.18−¥0.31—¥0.2822.29×
31 Dec 2025 年报¥6.04−¥0.37—¥0.3119.28×
30 Sep 2025 三季报¥9.11−¥0.53—¥0.3923.19×
30 Jun 2025 中报¥6.27−¥0.57—¥0.4813.12×
31 Mar 2025 一季报¥5.79−¥0.60—¥0.599.88×
31 Dec 2024 年报¥4.94−¥0.67—¥0.677.38×
30 Sep 2024 三季报¥4.86−¥0.71—¥0.875.61×
30 Jun 2024 中报¥4.35−¥0.76—¥1.004.35×
31 Mar 2024 一季报¥5.67−¥0.71—¥1.135.01×
31 Dec 2023 年报¥6.53−¥0.64—¥1.275.13×
30 Sep 2023 三季报¥6.92−¥0.44—¥1.544.50×
30 Jun 2023 中报¥8.55−¥0.36—¥1.715.01×
31 Mar 2023 一季报¥9.05−¥0.37—¥1.775.10×
31 Dec 2022 年报¥8.86−¥0.38—¥1.854.78×
30 Sep 2022 三季报¥7.00−¥0.50—¥1.923.65×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA